Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 exploratory clinical trial evaluating Benmelstobart with chemotherapy, with or without Anlotinib, in resectable limited-stage small cell lung cancer; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anlotinib (anlotinib)
  • Benmelstobart

Snippet

Sponsor: Tang-Du Hospital | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING